New cancer drug ANS014004 enters first human tests
NCT ID NCT06307795
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests a new drug called ANS014004 in 63 adults with advanced solid tumors that have spread. The main goals are to check safety, find the right dose, and see if the drug can shrink tumors. Participants must have certain genetic changes (MET, ROS1, or NTRK) and be healthy enough for treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED OR METASTATIC SOLID TUMORS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Advent Health
RECRUITINGOrlando, Florida, 32804, United States
-
BC Cancer Vancouver Centre
RECRUITINGVancouver, British Columbia, Canada
-
Beijing Chest Hospital
NOT_YET_RECRUITINGBeijing, Beijing Municipality, 101149, China
-
Harbin Medical University Cancer Hospital
NOT_YET_RECRUITINGHarbin, Heilongjiang, 150010, China
-
Henan Cancer Hospital
NOT_YET_RECRUITINGZhengzhou, Henan, 450008, China
-
Henry Ford Health Cancer
RECRUITINGDetroit, Michigan, 48202, United States
-
NEXT Oncology, Virginia
RECRUITINGFairfax, Virginia, 22031, United States
-
NYU Langone Health
RECRUITINGNew York, New York, 10003, United States
-
Princess Margaret Cancer Centre
RECRUITINGToronto, Ontario, Canada
-
Sarah Cannon Research Institute
RECRUITINGDenver, Colorado, 80218, United States
-
Shandong Cancer Hospital
NOT_YET_RECRUITINGJinan, Shandong, 250117, China
-
Shanghai Chest Hospital
NOT_YET_RECRUITINGShanghai, Shanghai Municipality, 200030, China
-
Swedish Cancer Institute
RECRUITINGSeattle, Washington, 98195, United States
-
The University of Texas - MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
University of California, San Diego
RECRUITINGSan Diego, California, 92093, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new Immune-Boosting pill make immunotherapy work better against Hard-to-Treat tumors?
- Can a new drug shrink Hard-to-Treat cancers? an early trial seeks answers
- Can a new drug ASP388B take on advanced solid tumors?
- Can a new infusion drug tame advanced solid tumors?
- New antibody drug takes aim at Hard-to-Treat cancers
- New cancer pill enters first human tests for advanced solid tumors